Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Salt mine therapy tested for COPD relief

NCT ID NCT07122544

Symptom relief Sponsor: University School of Physical Education, Krakow, Poland Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether doing pulmonary rehabilitation in underground salt chambers improves breathing, exercise ability, and quality of life in people with COPD. 80 adults with stable COPD will be split into four groups: rehab in salt chambers, rehab in a gym, just sitting in salt chambers, or health education only. Researchers will measure changes in walking distance, symptoms, and muscle strength right after the 16-day program and again three months later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pulmonary rehabilitation in therapeutic salt chambers
What this could lead to
If it works, this could offer a new way to improve exercise tolerance and quality of life for people with COPD.
What could go wrong
This is a small, early-stage study with 80 participants. The benefits of salt chamber therapy are unproven, and results may not apply to all COPD patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * COPD diagnosis confirmed by a pulmonology specialist according to the 2025 GOLD guidelines. * FEV1 ≥ 30% of the predicted value. * FEV1/FVC \< 0.7 after bronchodilator administration in spirometry. * Negative bronchodilator reversibility test. * Voluntary written consent to participate in the study. Exclusion Criteria: * COPD exacerbation. * Active cancer or a history of cancer within the past five years. * Musculoskeletal disorders preventing independent movement and participation in exercise tests and training included in the study protocol. * Recent (within six months) surgical procedure or trauma to the chest, abdomen, skull, brain, or eye area. * Severe valvular heart disease. * Implanted cardioverter-defibrillator. * Diagnosed arrhythmias posing a risk of loss of consciousness. * Acute coronary artery disease. * Epilepsy. * Uncontrolled arterial hypertension despite medication. * Primary or secondary immunodeficiencies. * Respiratory failure requiring chronic or intermittent oxygen therapy. * Infectious diseases with fever during the experiment or within two weeks before the study. * Claustrophobia. * Pregnancy. * Simultaneous participation in another rehabilitation program. * Significant changes in pharmacological treatment during the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD (chronic obstructive pulmonary disease) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COPD (chronic obstructive pulmonary disease)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AKF Kraków

    RECRUITING

    Krakow, Małopolska, 30-009, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.